Tesar V
Nefrologické oddĕlení I. interní kliniky 1. lékarské fakulty UK a VFN, Praha.
Vnitr Lek. 2003 May;49(5):383-7.
Patients with chronic renal failure have, as compared with age-matched controls with normal renal function, a markedly higher cardiovascular mortality. The reason is probably accelerated atherosclerosis and left ventricular hypertrophy as a result of accumulation of "classical" cardiovascular risk factors and the presence of some risk factors relatively specific for "uraemia" (e.g. anaemia, hyperhydratation, dyslipidaemia). It is assumed that the reversibility of left ventricular hypertrophy is limited in chronic renal failure due to more marked myocardial fibrosis ("uraemic cardiomyopathy"). Its regression can be achieved by treatment of hypertension with inhibitors of angiotensin converting enzyme with a positive effect on cardiovascular mortality. Regression of left ventricular hypertrophy occurs also in some patients after renal transplantation. Treatment of anaemia reduces the risk of progressive left ventricular dilatation. The cardiovascular risk increases probably already a relatively slight decline of glomerular filtration which need not lead to a significant rise of serum creatinine. The cardiovascular risk obviously increases further with progression of chronic renal insufficiency. Patients with a reduced renal function and chronic renal insufficiency have lower target blood pressure and should have also lower target values e.g. of serum cholesterol. Therapeutic procedures in these patients should not be focused only on a slower progression of chronic renal insufficiency but also on reduction of their high cardiovascular risk.
与肾功能正常的年龄匹配对照组相比,慢性肾衰竭患者的心血管死亡率显著更高。原因可能是“经典”心血管危险因素的累积以及一些相对特定于“尿毒症”的危险因素(如贫血、水钠潴留、血脂异常)导致动脉粥样硬化加速和左心室肥厚。据推测,由于更明显的心肌纤维化(“尿毒症性心肌病”),慢性肾衰竭患者左心室肥厚的可逆性有限。通过使用血管紧张素转换酶抑制剂治疗高血压可实现左心室肥厚的消退,这对心血管死亡率有积极影响。肾移植后,部分患者的左心室肥厚也会消退。治疗贫血可降低左心室进行性扩张的风险。心血管风险可能在肾小球滤过率相对轻微下降时就已增加,而这不一定会导致血清肌酐显著升高。随着慢性肾功能不全的进展,心血管风险显然会进一步增加。肾功能减退和慢性肾功能不全的患者目标血压较低,血清胆固醇等目标值也应更低。这些患者的治疗措施不应仅侧重于减缓慢性肾功能不全的进展,还应注重降低其高心血管风险。